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Abstract
OBJECTIVE: To investigate the apoptotic effects
and underlying molecular mechanisms of Celastrus
orbiculatus (C. orbiculatus) extract in human hepa-
tocellular carcinoma cells.
METHODS: Human hepatocellular carcinoma cells
(HCCLM6) were treated with C. orbiculatus extract
(COE) at different nontoxic concentrations (10, 20,
40, 80, and 160 μg/mL). The effect of COE on HC-
CLM6 viability was examined using 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assays. Cellular apoptosis following COE
treatment was assessed by flow cytometry and
western blot analysis.
RESULTS: COE significantly inhibited cell viability
and induced apoptosis of HCCLM6 cells in a
dose-dependent manner. Apoptosis was accompa-
nied by increased Bax expression and decreased
Bcl-2 expression. In addition, COE treatment led to
the release of cytochrome c, activation of cas-
pase-3, and cleavage of poly (ADP-ribose) poly-
merase (PARP). Furthermore, activation of extracel-
lular signal-regulated kinase (ERK), p38 kinase, and
c-Jun N-terminal kinase (JNK) phosphorylation, and
down-regulation of Akt phosphorylation was ob-
served.
CONCLUSION: COE induces mitochondrial-mediat-
ed, caspase-dependent apoptosis in HCCLM6 cells,
which might be attributed to the activation of mito-
gen-activated protein kinase (MAPK) and inhibition
of Akt signaling pathways. These data suggest that
COE may be a potential treatment for human hepa-
tocellular carcinoma.
© 2012 JTCM. All rights reserved.
Key words: Celastrus; Apoptosis; Carcinoma, hepa-
tocellular; Mitochondria; Caspases; Mitogen-activat-
ed protein kinase
INTRODUCTION
Hepatocellular carcinoma (HCC) accounts for 70%-
85% of the total liver cancer burden, and is one of the
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leading causes of cancer-related deaths worldwide.1 Re-
cent estimates suggest that half of all liver cancer
deaths in 2008 occurred in China.2 In addition, treat-
ments available for advanced HCC remain disappoint-
ing.3 New treatments to improve survival and increase
lasting remission among patients with advanced HCC
are urgently needed.
Over the past several decades, traditional Chinese herb-
al medicines have drawn wide attention because of
their various anticancer activities.4-6 Studies, especially
in China, have examined the effects of herbal medicine
in the prevention and treatment of HCC. Results
showed that herbal compounds were efficacious and
safe in preventing and treating HCC by affecting the
three phases of HCC: initiation, promotion, and pro-
gression, giving new hope for the development of
HCC prevention and treatment.4
The Celastraceae plant Celastrus orbiculatus (Celastrus
orbiculatus Thunb., Nansheteng, celastrus, C. orbicula-
tus) has traditionally been identified as an effective rem-
edy for arthritis and other inflammatory diseases in
China.7 Evaluation of its biological activities in the lab-
oratory revealed that C. orbiculatus extract (COE) ex-
erts potent antitumor activity with minimal adverse ef-
fects in vivo and in vitro.8-10 In our previous studies, the
biological effects of ethanol, water, and ethyl acetate ex-
tract from C. orbiculatus stem were examined, with
ethyl acetate extract displaying potent antitumor activi-
ty.11 However, the mechanisms underlying this activity
remain obscure, and further investigations are needed
to explore the potential of COE for clinical use.
In the present study, we examine the effects of COE on
apoptosis in the HCC cell line HCCLM6 and investi-
gate the underlying molecular mechanisms.
MATERIALS ANDMETHODS
Plant material
The stems of C. orbiculatus plants were purchased
from Guangzhou Zhixin Pharmaceutical Co. Ltd.
(Guangzhou, China) in 2007. The COE was prepared
and characterized at the department of Chinese Mate-
ria Medica Analysis, China Pharmaceutical University
(Nanjing, China). The preparation procedure has been
described previously.11 Briefly, dried stems of C. orbicu-
latus were minced, extracted with 95% ethanol, fil-
tered, and evaporated to dryness. The extract was evac-
uated with a membrane pump to remove residual sol-
vent. The aqueous layer was then partitioned from the
ethanol extract with ethyl acetate. Finally, the ethanol
extract was condensed and lyophilized into powder and
stored at 4°C. Extraction yields of 1.7% (W/W) were
obtained using this procedure.12 Chemical constituents
and the proportion of COE stem were confirmed by ul-
traviolet (UV), infrared radiation (IR), proton nuclear
magnetic resonance spectroscopy (1H-NMR), carbon 13
nuclear magnetic resonance spectroscopy (13C-NMR),
and mass spectroscopy (MS) analysis, as described.11
The resultant COE micropowder was dissolved in di-
methyl sulfoxide (DMSO, Sigma-Aldrich Co., St Lou-
is, MO, USA) and diluted to different concentrations
before use. The final concentration of DMSO in the
cell medium did not exceed 0.1% (μg/mL COE). In
this study, the concentration was expressed as the
amount of COE per milliliter of media bathing the
cells .
Cell culture
The HCC cell line HCCLM6 was purchased from the
Liver Cancer Institute, (Zhongshan Hospital, Fudan
University, Shanghai, China), and maintained in Dul-
becco's modified eagle medium (DMEM, Invitrogen
Corporation, Carlsbad, CA, USA) containing 10% fe-
tal bovine serum (Gibco BRL, Gaithersburg, MD,
USA) and 100 μg/mL penicillin at 37°C in a humidi-
fied atmosphere containing 5% CO2.
Cell viability assay
The effect of COE on the proliferation and viability of
HCCLM6 cells was determined using the 3-(4, 5-di-
methylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide
(MTT) assay. Briefly, 1 × 104 cells were seeded in
96-well plates and cultured for 24 h. Serial concentra-
tions (10, 20, 40, 80, and 160 μg/mL) of COE were
added and cells cultured for 24, 48 h. Media were dis-
carded and cells washed twice with phosphate-buffered
saline (PBS) before 20 μl MTT solution (5 mg/mL in
culture medium) was added to each well and incubated
for an additional 4 h at 37°C. To achieve solubilization
of formazan crystals that formed in viable cells, 100 μl
DMSO was added to each well, and plates placed in
the dark with continuous gentle shaking for 30 min to
dissolve the MTT dye. Spectrometric absorbance at
490 nm was measured using a Model 680 microplate
reader (BIO-RAD, Hercules, CA, USA), to determine
the number of live cells. We used 0 μg/mL COE and
5-fluorouracil (5-FU; 180 μg/mL) treated cells as nega-
tive and positive controls, respectively.
Apoptosis assay
Apoptotic cells were detected using the Annexin V as-
say. HCCLM6 cells were seeded at densities of 1×106
cells/well in 6-well plates. After incubation with COE
at various concentrations (10, 20, 40, 80, and 160 μg/
mL) for 24 h, cells were washed with PBS twice and
suspended in 100 μL binding buffer. Annexin V-Alexa
Fluor 488 (50 mg/mL, 5 μL) and propidium iodide
(PI, 50 mg/mL, 5 μL) were then added, followed by in-
cubation at room temperature in the dark for 15 min
(using the Annexin V-Alexa Fluor 488 Apoptosis De-
tection Kit according to the manufacturer's instruc-
tions (Invitrogen Corporation, Carlsbad, CA, USA).
Alexa and PI fluorescence were detected using a FACS-
can (Becton, Dickinson and Company, San Jose, CA,
USA) by FL1 (Alexa Fluor 488 detector, Becton, Dick-
inson and Company, San Jose, CA, USA) at 530 nm
and FL2 at 620 nm, respectively. Fluorescence parame-
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ters were gated using unstained and single-stained con-
trol cells without COE treatment. 10 000 cells were
counted for each sample. Rates of early apoptotic (An-
nexin+/PI−) were analyzed using the FACSDiva (Bec-
ton, Dickinson and Company) software. At least
10000 events were recorded for each sample.
Immunoblot analysis
HCCLM6 cells were washed with cold PBS and lysed
for 20 min on ice with lysis buffer [50 mM Tris/HCl
(pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
25mM NaF, 50 mM Na4Ppi, 1% Triton X-100, 5 mM
Na3VO4, 2 μg/mL leupeptin, 2 μg/mL aprotinin, 3.5μg/mL pepstatin and 100 μg/mL PMSF] and centri-
fuged at 15 000 r/min for 10 min at 4°C. The cytosol
extraction buffer was used for the isolation of cytosolic
protein. Protein concentration was measured using the
Bradford assay kit (BIO-RAD). Equal amounts of pro-
tein from each sample were subjected to SDS-PAGE
and transferred to nitrocellulose membranes. After
blocking in 5% nonfat dried milk in TBS-T for 2 h at
room temperature, membranes were incubated at 4°C
overnight with primary antibodies. Primary antibodies
and their sources were as follows: B cell lymphoma/
lewkmia-2 (Bcl-2), Bax, and cytochrome C (Santa
Cruz Biotechnology, Ltd. Santa Cruz, CA, USA),
cleaved caspase-3, phospho-specific antibodies to p38,
c-Jun N-terminal kinases (JNK), Akt (Thr308), p38,
JNK, and Akt (Cell Signaling Technology, Inc. Dan-
vers, MA, USA), poly (ADP-ribose) polymerase
(PARP), extracellular-receptor kinases (ERK1/2), phos-
phor- ERK1/2 (Promega Co. Madison, WI, USA), andβ-actin (Sigma-Aldrich Co. St Louis, MO, USA).
Membranes were washed 5× with TBS-T, and incubat-
ed with secondary antibody for 2 h at room tempera-
ture. Proteins were visualized using the ECL SuperSig-
nal West Pico Kit (Thermo Scientific, Rockford, IL,
USA) and exposed to Kodak X-OMAT film (Kodak,
Rochester, NY, USA).
Statistical analysis
SPSS ver17.0 software (IBM, Armonk, NY, USA) was
used for data analyses. Differences between groups
were compared using the independent samples t-test. P
values <0.05 were considered statistically significant.
RESULTS
COE Inhibits viability of HCCLM6 cells
HCCLM6 cells were treated with various concentra-
tions of COE for 24 and 48 h. MTT assay showed
that COE treatment significantly (P<0.05) inhibited
the proliferation and growth of HCCLM6 cells in
both a concentration- and time-dependent manner. Af-
ter 24 h COE treatment, the rates of inhibition were
5.1%, 8.4%, 14.9%, 17.3% and 30.4% for 10, 20, 40,
80, and 160 μg/mL COE, respectively.While exposure
of HCCLM6 cells to COE (10-160 μg/mL) for 48 h,
the inhibition ratios further increased to 12.1%, 27.5%,
30.3%, 37.9%, 51.4%, respectively. These data suggest
that COE has a broad inhibitory effect on the growth
and survival of HCCLM6 cells.
COE induces apoptosis in HCCLM6 cells
HCCLM6 cells treated with COE exhibited morpho-
logic characteristics of apoptosis, including a smaller cy-
toplasm, condensed chromatin, and nuclear fragmenta-
tion with intact cell membranes. To further confirm
the apoptotic effects of COE on HCCLM6 cells, the
percentage of cells undergoing apoptosis was measured
by flow cytometry. Treatment of HCCLM6 cells with
COE (10, 20, 40, 80, and 160 μg/mL) for 24 h result-
ed in increased percentages of early apoptotic cells
(3.8%±7.1%, 6.6%±1.3%, 7.8%±1.9%, 10.0%±2.1%,
20.1%±3.2%, respectively) in a concentration-depen-
dent manner compared with the negative control
group (3.5%±1.2%, P<0.05).
COE regulated expression of Bcl-2, Bax, and release
of cytochrome C
Since regulated Bax and Bcl-2 expression in turn regu-
lates apoptosis in HCC,13 we examined expression lev-
els of Bcl-2 and Bax by western blotting. Exposure of
HCCLM6 cells to COE (10, 20, 40, 80 and 160 μg/
mL) for 24 h increased Bax protein levels, whereas
Bcl-2 protein levels decreased gradually with increasing
COE concentration (Figure 1). Thus, COE treatment
increased the ratio of Bax/Bcl-2, which favors the oc-
currence of apoptosis.
Bcl-2 plays a critical role in controlling cytochrome re-
lease, a known mediator of apoptotic pathways, from
mitochondria into the cytosol. To determine whether
COE induces cytochrome c release, we assayed cytosol-
ic extracts of COE-treated cells. Results show a concen-
tration-dependent increase in the release of cytochrome
c into the cytoplasm (Figure 1).
COE-induced activation of caspases-3 and PARP
Caspases act as pivotal mediators of apoptosis. Cas-
pase-3, a primary effector caspase, represents a key pro-
tease responsible for cleavage of PARP and subsequent
apoptosis. Therefore, we investigated the cleavage of
caspase-3 and PARP in HCCLM6 cells treated with
COE for 24 h. As shown in Figure 2, western blot anal-
ysis revealed that COE treatment at ≥80 μg/mL signifi-
cantly induced cleavage of caspase-3 and PARP in a
concentration-dependent manner. These results indi-
COE (μg/mL)
0 10 20 40 80 160 5-Fu
Figure 1 Effects fo COE on expressions of Bcl-2 and Bax and
cytochrome C release
COE: C. orbiculatus extract .
Bax
Bcl-2
Cytochrome c
β-actin
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cate that COE induces apoptosis in HCCLM6 cells, at
least in part, through a caspase-dependent pathway.
COE modulated activation of MAPKs and
inactivation of akt in HCCLM6 cells
MAPKs and Akt are important pathways associated
with tumor development. To determine whether these
signaling pathways are involved in mediating the ob-
served apoptotic response, we investigated the effect of
COE treatment on the expression and activity of
MAPKs and Akt. As shown in Figure 3, treatment
with COE (10, 20, 40, 80, 160 μg/mL) for 24 h led to
ERK, p38 MAPK and JNK activation. Results suggest
that COE exerts a concentration-dependent effect on
p38 MAPK and JNK. In contrast, phosphorylation of
Akt kinase was clearly decreased by COE treatment in
a concentration-dependent manner (Figure 4). These
results indicate that interference with ERK, p38
MAPK, JNK, and Akt signaling pathways might con-
tribute to the anticancer activity of COE.
DISCUSSION
Growing scientific evidence and clinical trial results
suggest that herbal medicine is a potential source of
new anticancer compounds.14,15 Recently, anticancer ef-
fects of herbal extracts have been demonstrated in sev-
eral studies.16-20 COE, an extract isolated from the stems
of C. orbiculatus plants, has also been shown by us to
have anticancer activity.11,21-23 Compared with isolating
active components from herbs, preparing herb extracts
seems more convenient and can also help stabilize its
active components. Some studies further confirmed
that the activity of herb extract is because of synergy
within the extract itself and not because of a single sub-
set of compounds or molecules. That is, various herbal
extract components may have synergistic activities and
buffer the toxicity of a single compound. Assuring the
quality and efficacy of the derived herbal extract is a
pivotal problem in the development of botanical prepa-
rations.24To accomplish consistent C. Orbiculatus prep-
arations, the active components of C. Orbiculatus
stems were first identified. To make the current study
possible, we developed an extraction procedure for as-
suring the quality and consistency of COE.
Apoptosis is an evolutionarily conserved process need-
ed for cell development, tissue homeostasis, and im-
mune system regulation. In cancer, the balance be-
tween proliferation and programmed cell death is dis-
turbed, and defects in apoptotic pathways allow cells
with genetic abnormalities to survive.25 Induction of
apoptosis is considered the major cytotoxic mechanism
of anticancer therapies. Generally, mitochondrial and
death receptor-mediated signaling pathways are the
two principal pathways leading to apoptosis.26, 27 The
mitochondrial pathway, triggered by intracellular cues,
is mediated by Bcl-2 family proteins, which contains
several proteins with opposing activity. Pro-apoptotic
Bcl-2 family proteins such as Bax induce a decrease in
mitochondrial membrane potential and an opening of
mitochondrial permeability, leading to cytochrome c re-
lease from mitochondria into the cytosol, and activat-
ing downstream apoptotic signals.28 On the other hand,
antiapoptotic Bcl-2 family members such as Bcl-2 and
Bcl-xL counter these effects. The relative ratio of pro-
and antiapoptotic Bcl-2 family proteins dictate the ulti-
mate sensitivity or resistance of cells to various apoptot-
ic stimuli.29 COE treatment induced a significant in-
crease in Bax expression and a decrease of Bcl-2 expres-
sion in HCCLM6 cells, suggesting that COE changes
the balance between antiapoptotic and pro-apoptotic
protein members of the Bcl-2 family, leading eventual-
ly to apoptotic activity.
The release of cytochrome c into the cytosol, one of
the early events leading to apoptosis,30 triggers the for-
mation of the apoptosome, resulting in caspase activa-
tion.31 Results obtained in the present study demon-
strate that treatment of HCCLM6 cells with COE for
COE (μg/mL)
0 10 20 40 80 160 5-Fu
Figure 2 Effects fo COE on cleavage of caspase-3 and PARP
PARP: polymerase; COE: C. orbiculatus extract.
procaspase-3
cleaved caspase-3
PARP
cleaved PARP
β-actin
COE (μg/mL)
0 10 20 40 80 160 5-Fu
Figure 3 Effects fo COE on activation of MARK pathways
COE: C. orbiculatus extract; MARK: mitogen-activated pro-
tein kinaseERK: extracellular-receptor kinases; JNK: c-Jun
N-terminal kinases.
Total ERK1/2
p-ERK1/2
Total JNK
p-KNK
Total P38
p-P38
β-actin
COE (μg/mL)
0 10 20 40 80 160 5-Fu
Akt
p-Akt
β-actin
Figure 4 Effects fo COE on inactivation of Akt pathways
COE: C. orbiculatus extract.
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24 h leads to a concentration-dependent increase in cy-
tosolic cytochrome c, suggesting cytochrome c is re-
leased from mitochondria during COE-induced apop-
tosis in HCCLM6 cells.
The mitochondrial apoptosis pathway may be cas-
pase-dependent or caspase-independent. Among the
family of caspases, caspase-3 has been identified as the
primary effector caspase in most mammalian cells. It al-
so plays an important role in determining the cellular
sensitivity to diverse apoptotic stimuli.32 Moreover, cas-
pase-3 activation is often considered as the
point-of-no-return in the apoptotic signaling cascade.33
In the present study, PARP, a specific enzymatic sub-
strate for caspase-3,34 clearly produced apoptotic frag-
ments, indicating COE mediated apoptosis is cas-
pase-dependent in HCCLM6 cells.
Mitogen-activated protein kinases (MAPKs) play a crit-
ical role in complex cellular programs such as prolifera-
tion, differentiation, development, transformation, and
apoptosis. MAPKs mediate intracellular signaling,
which is initiated by a variety of extracellular stimuli. 35
In mammalian cells, five major groups of MAP kinases
have been clearly characterized, including ERK, JNK/
SAPK (C-Jun N-terminal Kinase/ Stress-Activated Pro-
tein Kinase) and p38 Kinase.36 Previous studies have
shown that Bax may be a potential target of JNK. Bax
expression and cytochrome c were both inhibited by
JNK inhibitors.35 In the present study, COE elevated
phosphorylated JNK and p38 in a concentration-de-
pendent manner, which favored increased Bax expres-
sion and further modulation of the mitochondrial path-
way in cell apoptosis.
ERKs are often activated by growth signals and are
mostly associated with cellular survival and prolifera-
tion. However, the ability of an ERK pathway to regu-
late proliferation versus survival appears to depend on
cell type and the amplitude and duration of ERK acti-
vation. Sometimes ERK activation shows an opposite
biological effect. Studies indicate that indirect apopto-
sis following ERK activation could not be ruled out.37
For example, sustained activation of ERK is required
for quercetin-induced apoptosis in A549 cells.38 A role
for ERK activation in fucoidan-induced growth inhibi-
tion and apoptosis in HCT-15 colon carcinoma cells
was also observed in another study.39 Our study sug-
gests that COE treatment also results in strong activa-
tion of ERK in HCCLM6 cells, although with no obvi-
ous dose-effect. Vital questions that need to be an-
swered are whether ERK activation leads to apoptosis
of COE-treated HCCLM6 cells accompanied by other
signaling pathways, or was there some antagonism to
apoptosis, led by ERK? All these demonstrate that the
effect and mechanisms of ERK activation in
COE-treated HCCLM6 cells deserve further experi-
mental clarification.
Akt, a Ser/Thr kinase activated via phosphatidylinosi-
tol 3-kinase, is a prominent mediator of cellular surviv-
al, and proliferates in a wide variety of cancer cells.40
Phosphorylated Akt exerts antiapoptotic effects
through activation of substrates that directly regulate
the apoptosis machinery (Bad or caspase-9). Bad is a
pro-apoptotic protein of the Bcl-2 family. Akt could
phosphorylate Bad, making Bad dissociate from the
Bcl-2/Bcl-X complex and lose the pro-apoptotic func-
tion. Conversely, inactivation of Akt usually attenuates
Bcl-2 levels.41 Thus, development and application of
chemotherapeutic agents that target blocking Akt activ-
ity has become an increasingly attractive strategy for
cancer therapy.42 We observed that COE treatment
caused a decrease in Akt phosphorylation and, in turn,
modulated Bcl-2 family proteins in HCCLM6 cells.
These results suggest that Akt might be a target inhibit-
ed by COE in HCCLM6 cells.
In summary, although the exact mechanisms and ef-
fects of COE in cancer therapy need further investiga-
tion, our results provide a clue. It will be important to
understand how inducing apoptosis in HCCLM6 oc-
curs through multiple targets, such as activation of
ERK, JNK, p38 kinase and inactivation of Akt. Akt (,
which) then co-stimulates an increase in Bax levels,
with a concomitant decrease in Bcl-2 levels, triggering
the mitochondrial apoptotic pathway (Cytochrome c
release and caspase activation). Our data suggest that
COE may have potential as a hepatocellular carcinoma
therapeutic agent.
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